183 related articles for article (PubMed ID: 36305018)
1. What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.
Frey MK; Ahsan MD; Badiner N; Lin J; Narayan P; Nitecki R; Rauh-Hain JA; Moss H; Fowlkes RK; Thomas C; Bergeron H; Christos P; Levi SR; Blank SV; Holcomb K; Cantillo E; Sharaf RN; Lipkin S; Offit K; Chapman-Davis E
Cancer; 2022 Dec; 128(24):4241-4250. PubMed ID: 36305018
[TBL] [Abstract][Full Text] [Related]
2. Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
Frey MK; Kahn RM; Chapman-Davis E; Tubito F; Pires M; Christos P; Anderson S; Mukherjee S; Jordan B; Blank SV; Caputo TA; Sharaf RN; Offit K; Holcomb K; Lipkin S
J Clin Oncol; 2020 May; 38(13):1389-1397. PubMed ID: 31922918
[TBL] [Abstract][Full Text] [Related]
3. Cascade Genetic Risk Education and Testing in Families With Hereditary Cancer Syndromes: A Pilot Study.
Katz SJ; Abrahamse P; Hodan R; Kurian AW; Rankin A; Tocco RS; Rios-Ventura S; Ward KC; An LC
JCO Oncol Pract; 2023 Jun; 19(6):e848-e858. PubMed ID: 36921235
[TBL] [Abstract][Full Text] [Related]
4. Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?
Kahn RM; Ahsan MD; Chapman-Davis E; Holcomb K; Nitecki R; Rauh-Hain JA; Fowlkes RK; Tubito F; Pires M; Christos PJ; Tkachuk K; Krinsky H; Sharaf RN; Offit K; Lipkin S; Frey MK
Fam Cancer; 2023 Apr; 22(2):127-133. PubMed ID: 36207653
[TBL] [Abstract][Full Text] [Related]
5. Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
Frey MK; Ahsan MD; Bergeron H; Lin J; Li X; Fowlkes RK; Narayan P; Nitecki R; Rauh-Hain JA; Moss HA; Baltich Nelson B; Thomas C; Christos PJ; Hamilton JG; Chapman-Davis E; Cantillo E; Holcomb K; Kurian AW; Lipkin S; Offit K; Sharaf RN
J Clin Oncol; 2022 Dec; 40(35):4129-4143. PubMed ID: 35960887
[TBL] [Abstract][Full Text] [Related]
6. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
[TBL] [Abstract][Full Text] [Related]
7. Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review.
Grutters LA; Christiaans I
Fam Cancer; 2024 Jun; 23(2):155-164. PubMed ID: 38184510
[TBL] [Abstract][Full Text] [Related]
8. Impact of BRCA1/2 cascade testing on anxiety, depression, and cancer worry levels among unaffected relatives in a multiethnic Asian cohort.
Padmanabhan H; Mariapun S; Lee SY; Hassan NT; Lee DS; Meiser B; Wong SW; Lee YQ; Yip CH; Teo SH; Thong MK; Taib NAM; Yoon SY
J Genet Couns; 2023 Feb; 32(1):43-56. PubMed ID: 35913122
[TBL] [Abstract][Full Text] [Related]
9. Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.
Levine R; Kahn RM; Perez L; Brewer J; Ratner S; Li X; Yeoshoua E; Frey MK
Fam Cancer; 2024 Jun; 23(2):111-120. PubMed ID: 38530571
[TBL] [Abstract][Full Text] [Related]
10. Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives.
Heald B; Pirzadeh-Miller S; Ellsworth RE; Nielsen SM; Russell EM; Beitsch P; Esplin ED; Nussbaum RL; Pineda-Alvarez DE; Kurian AW; Hampel H
J Natl Cancer Inst; 2024 Feb; 116(2):334-337. PubMed ID: 37756683
[TBL] [Abstract][Full Text] [Related]
11. Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease.
Rasmussen A; Alonso E; Ochoa A; De Biase I; Familiar I; Yescas P; Sosa AL; Rodríguez Y; Chávez M; López-López M; Bidichandani SI
BMC Med Genet; 2010 Jan; 11():4. PubMed ID: 20064270
[TBL] [Abstract][Full Text] [Related]
12. Cascade genetic testing: an underutilized pathway to equitable cancer care?
Wilke RN; Bednar EM; Pirzadeh-Miller S; Lahiri S; Scarinci IC; Leath Iii CA; Frey MK; Lu KH; Rauh-Hain JA
Fam Cancer; 2024 Jun; 23(2):141-145. PubMed ID: 38748383
[TBL] [Abstract][Full Text] [Related]
13. Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study.
Bednar EM; Rauh-Hain JA; Garcia JJ; de Aguinaga N; Powell MA; Peral SL; Nitecki R; Jorgensen K; Rudy NL; Lu KH; Leath CA; Scarinci IC
Cancer Prev Res (Phila); 2024 Jan; 17(1):19-28. PubMed ID: 37913800
[TBL] [Abstract][Full Text] [Related]
14. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
[TBL] [Abstract][Full Text] [Related]
15. Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.
Caswell-Jin JL; Zimmer AD; Stedden W; Kingham KE; Zhou AY; Kurian AW
J Natl Cancer Inst; 2019 Jan; 111(1):95-98. PubMed ID: 30239769
[TBL] [Abstract][Full Text] [Related]
16. Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy.
Caeser R; Chiang J; Tan ES; Tai ES; Ngeow J
Fam Cancer; 2024 Jun; 23(2):133-140. PubMed ID: 38662262
[TBL] [Abstract][Full Text] [Related]
17. Outcomes from a pilot genetic counseling intervention using motivational interviewing and the extended parallel process model to increase cascade cholesterol screening.
Baldry E; Redlinger-Grosse K; MacFarlane I; Walters ST; Ash E; Steinberger J; Murdy K; Cragun D; Allen-Tice C; Zierhut H
J Genet Couns; 2022 Feb; 31(1):164-175. PubMed ID: 34260792
[TBL] [Abstract][Full Text] [Related]
18. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
[TBL] [Abstract][Full Text] [Related]
19. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
20. Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes.
Manchanda R; Burnell M; Gaba F; Desai R; Wardle J; Gessler S; Side L; Sanderson S; Loggenberg K; Brady AF; Dorkins H; Wallis Y; Chapman C; Jacobs C; Legood R; Beller U; Tomlinson I; Menon U; Jacobs I
BJOG; 2020 Feb; 127(3):364-375. PubMed ID: 31507061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
